PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $141,000 | 0.0% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $141,000 | 0.0% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $141,000 | 0.0% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $141,000 | -21.7% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $180,000 | +8.4% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $166,000 | +3.1% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $161,000 | -13.0% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $185,000 | +50.4% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $123,000 | -31.3% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $179,000 | -15.6% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $212,000 | +28.5% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $165,000 | +10.0% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $150,000 | +12.8% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $133,000 | -20.8% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $168,000 | +7.7% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $156,000 | -19.2% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $193,000 | +36.9% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $141,000 | +9.3% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $129,000 | +6.6% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $121,000 | -36.6% | 57,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $191,000 | +6.7% | 57,000 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $179,000 | -5.8% | 57,000 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $190,000 | -5.9% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $202,000 | -29.6% | 57,000 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $287,000 | -21.8% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $367,000 | -8.5% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $401,000 | -8.7% | 57,000 | 0.0% | 0.00% | -25.0% |
| Q4 2014 | $439,000 | +3.1% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $426,000 | -22.8% | 57,000 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $552,000 | +16.5% | 57,000 | 0.0% | 0.01% | +25.0% |
| Q1 2014 | $474,000 | -1.5% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $481,000 | +5.9% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $454,000 | +3.2% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $440,000 | – | 57,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |